Thrombolysis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:30:35 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Thrombolysis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-bay-3018250-and-low-molecular-weight-heparin-for-patients-with-proximal-deep-vein-thrombosis/ Wed, 29 Apr 2026 14:26:19 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-bay-3018250-and-low-molecular-weight-heparin-for-patients-with-proximal-deep-vein-thrombosis/ This clinical trial is focused on studying a condition known as proximal deep vein thrombosis (DVT), which is a type of blood clot that forms in the deep veins, usually in the legs. The study is investigating a treatment called BAY 3018250, which is a concentrate for solution for infusion. This means it is a liquid form of medication that is given through a needle into a vein. The trial will also involve a comparison with a placebo solution to help understand the effects of the treatment.

The purpose of the study is to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis. Participants in the study will receive either the treatment or a placebo, and their progress will be monitored over a period of time. The study will look at how the treatment affects the blood clot and any side effects that may occur. The trial will also involve the use of low molecular weight heparin, a type of medication that helps prevent blood clots, given by injection under the skin.

Throughout the study, participants will have regular check-ups to assess the size of the blood clot and any changes in symptoms, such as leg pain. These assessments will be done using ultrasound, a method that uses sound waves to create images of the inside of the body. The study will last for several months, with follow-up visits to monitor the participants’ health and the effectiveness of the treatment. The goal is to provide valuable information that could lead to better treatment options for people with proximal deep vein thrombosis.

]]>